selected publications
- CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response. Oncoimmunology. 2023 Academic Article GET IT
- Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. Nature communications. 2023 Academic Article GET IT
- Radiation therapy-induced remodeling of the tumor immune microenvironment. Seminars in cancer biology. 2022 Review GET IT
- hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote its translation in stressed melanoma cells. Molecular oncology. 2021 Academic Article GET IT
-
Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control.
The Journal of clinical investigation.
2021
Academic Article
GET IT
Times cited: 145 -
IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection.
Oncoimmunology.
2020
Information Resource
GET IT
Times cited: 6 -
Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 32 -
Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells.
Oncoimmunology.
2019
Academic Article
GET IT
Times cited: 40 - Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, France. Immunotherapy. 2017 Conference Paper GET IT
-
IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens.
Oncotarget.
2016
Academic Article
GET IT
Times cited: 45 -
The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences.
PloS one.
2013
Academic Article
GET IT
Times cited: 28